EIF3K
Eukaryotic translation initiation factor 3 subunit K
Also known as: ARG134, EIF3K_HUMAN, EIF3S12, HSPC029, M9, PLAC-24, PRO1474, PTD001
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UBQ5
- Gene
- EIF3K
- Ensembl
- ENSG00000178982
- Chromosome
- 19
- Canonical length
- 218 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
The 700-kD eukaryotic translation initiation factor-3 (eIF3) is the largest eIF and contains at least 12 subunits, including EIF2S12. eIF3 plays an essential role in translation by binding directly to the 40S ribosomal subunit and promoting formation of the 40S preinitiation complex (Mayeur et al., 2003 [PubMed 14519125]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
218 residues, UniProt reviewed canonical sequence.
>Q9UBQ5|EIF3K
1 MAMFEQMRAN VGKLLKGIDR YNPENLATLE RYVETQAKEN AYDLEANLAV LKLYQFNPAF
61 FQTTVTAQIL LKALTNLPHT DFTLCKCMID QAHQEERPIR QILYLGDLLE TCHFQAFWQA
121 LDENMDLLEG ITGFEDSVRK FICHVVGITY QHIDRWLLAE MLGDLSDSQL KVWMSKYGWS
181 ADESGQIFIC SQEESIKPKN IVEKIDFDSV SSIMASSQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EIF3K can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 749 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 749 nTPM
- heart muscle: 639 nTPM
- tongue: 431 nTPM
- kidney: 372 nTPM
- skin: 316 nTPM
- esophagus: 314 nTPM
Single-cell type
- esophageal suprabasal cells: 1,087 nCPM
- esophageal basal cells: 1,055 nCPM
- esophageal apical cells: 774 nCPM
- hofbauer cells: 773 nCPM
- enterocytes: 739 nCPM
- decidual stromal cells: 707 nCPM
Immune cell
- total PBMC: 442 nTPM
- myeloid DC: 360 nTPM
- non-classical monocyte: 307 nTPM
- intermediate monocyte: 298 nTPM
- T-reg: 297 nTPM
- classical monocyte: 269 nTPM
Brain region
- choroid plexus: 84 nTPM
- white matter: 67 nTPM
- cerebellum: 66 nTPM
- thalamus: 65 nTPM
- medulla oblongata: 63 nTPM
- spinal cord: 61 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.82
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.76
- DepMap mean gene effect
- -0.29
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- formation of cytoplasmic translation initiation complex
- regulation of translational initiation
- translational initiation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Proteasome component (PCI) domain
- Armadillo-type fold
- CSN8/PSMD8/EIF3K
- Winged helix-like DNA-binding domain superfamily
- Winged helix DNA-binding domain superfamily
- CSN8/PSMD8/EIF3K family
- Eukaryotic translation initiation factor 3 subunit K
- Translation initiation factor 3, subunit 12, N-terminal, eukaryotic
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EIF3K in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EIF3K as an antibody target. Whether an autoantibody or antibody against EIF3K could matter depends on whether native EIF3K is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EIF3K is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EIF3K as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...